Conformational Stability of PrP Amyloid Fibrils Controls Their Smallest Possible Fragment Size

Journal of Molecular Biology

Volumn 376, Issue 4, 2008, Pages 1155-1167

  Sun, Ying ^a   Makarava, Natallia ^a   Lee, Cheng I ^a   Laksanalamai, Pongpan ^a   Robb, Frank T ^a   Baskakov, Ilia V ^a,b  

^a UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

amyloid fibrils; chaperones; conformational stability; fibril fragmentation; prion protein

Indexed keywords

AMYLOID; CRYSTALLIN; PRION PROTEIN; SMALL HEAT SHOCK PROTEIN;

ARTICLE; ATOMIC FORCE MICROSCOPY; BETA SHEET; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DENATURATION; FRAGMENTATION REACTION; GROWTH; INCUBATION TIME; MECHANICAL STRESS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

MAMMALIAN PRION;

EID: 39049119728     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.12.053     Document Type: Article

References (47)

1. Legname G., Nguyen H.-O.B., Peretz D., Cohen F.E., DeArmond S.J., and Prusiner S.B. Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc. Natl Acad. Sci. USA 103 (2006) 19105-19110
2. Legname G., Nguyen H.-O.B., Baskakov I.V., Cohen F.E., DeArmond S.J., and Prusiner S.B. Strain-specified characteristics of mouse synthetic prions. Proc. Natl Acad. Sci. USA 102 (2005) 2168-2173
3. Legname G., Baskakov I.V., Nguyen H.-O.B., Riesner D., Cohen F.E., DeArmond S.J., and Prusiner S.B. Synthetic mammalian prions. Science 305 (2004) 673-676
4. Baskakov I.V., and Breydo L. Converting the prion protein: what makes the protein infectious. Biochim. Biophys. Acta (Molecular Basis of Disease) 1772 (2007) 692-703
5. Baskakov I.V. Branched chain mechanism of polymerization and ultrastructure of prion protein amyloid fibrils. FEBS J. 274 (2007) 3756-3765
6. Baskakov I.V., and Bocharova O.V. In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features. Biochemistry 44 (2005) 2339-2348
7. Sun Y., Breydo L., Makarava N., Yang Q., Bocharova O.V., and Baskakov I.V. Site-specific conformational studies of PrP amyloid fibrils revealed two cooperative folding domains within amyloid structure. J. Biol. Chem. 282 (2007) 9090-9097
8. Sc. J. Mol. Biol. 346 (2005) 645-659
9. Breydo L., Bocharova O.V., Makarava N., Salnikov V.V., Anderson M., and Baskakov I.V. Methionine oxidation interferes with conversion of the prion protein into the fibrillar proteinase K-resistant conformation. Biochemistry 44 (2005) 15534-15543
10. Santoro M.M., and Bolen D.W. Unfolding free energy changes determined by the linear extrapolation method: 1. Unfolding of phenylmethanesulfonyl alpha-chymotrypsin using different denaturants. Biochemistry 27 (1988) 8063-8068
11. Sc. Protein Sci. 14 (2005) 1222-1232
12. Novitskaya V., Makarava N., Bellon A., Bocharova O.V., Bronstein I.B., Williamson R.A., and Baskakov I.V. Probing the conformation of the prion protein within a single amyloid fibril using a novel immunoconformational assay. J. Biol. Chem. 281 (2006) 15536-15545
13. Anderson M., Bocharova O.V., Makarava N., Breydo L., Salnikov V.V., and Baskakov I.V. Polymorphism and ultrastructural organization of prion protein amyloid fibrils: an insight from high resolution atomic force microscopy. J. Mol. Biol. 358 (2006) 580-596
14. Makarava N., Bocharova O.V., Salnikov V.V., Breydo L., Anderson M., and Baskakov I.V. Dichotomous versus palm-type mechanisms of lateral assembly of amyloid fibrils. Protein Sci. 15 (2006) 1334-1341
15. Shorter J., and Lindquist S. Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers. Science 304 (2004) 1793-1797
16. Horwitz J. Alpha-crystallin. Exp. Eye Res. 76 (2003) 145-153
17. Kato S., Hirano A., Umahara T., Llena J.F., Herz F., and Ohama E. Ultrastructural and immunohistochemical studies on ballooned cortical neurons in Creutzfeldt-Jakob disease: expression of αB-crystallin, ubiquitin and stress-response protein 27. Acta Neuropathol. 84 (1992) 443-448
18. Renkawek K., de Jong W.W., Merck K.B., Frenken C.W.G.M., van Workum F.P.A., and Bosman G.J.C.G.M. αB-Crystallin is present in reactive glia in Creutzfeldt-Jakob disease. Acta Neuropathol. 83 (1992) 324-327
19. Iwaki T., Wisniewski T., Iwaki A., Corbin E., Tomokane N., Tateishi J., and Goldman J.E. Accumulation of αB-crystallin in central nervous system glia and neurons in pathologic conditions. Am. J. Pathol. 140 (1992) 345
20. Laksanalamai P., and Robb F.T. Small heat shock proteins from extremophiles: a review. Extremophiles 8 (2004) 1-11
21. Tanaka M., Collins S.R., Toyama B.H., and Weissman J.S. The physical basis of how prion conformations determine strain phenotypes. Nature 442 (2006) 585-589
22. Tanaka M., Chien P., Naber N., Cooke R., and Weissman J.S. Conformational variations in an infectious protein determine prion strain differences. Nature 6980 (2004) 323-328
23. Lu X., Wintrode P.L., and Surewicz W.K. Beta-sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchange. Proc. Natl Acad. Sci. USA 104 (2007) 1510-1515
24. Toyama B.H., Kelly M.J.S., Gross J.D., and Weissman J.S. The structural basis of yeast prion strain variants. Nature 449 (2007) 233-239
25. Peretz D., Scott M., Groth D., Williamson A., Burton D., Cohen F.E., and Prusiner S.B. Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci. 10 (2001) 854-863
26. Scott M.R., Peretz D., Nguyen H.-O., DeArmond S.J., and Prusiner S.B. Transmission barriers for bovine, ovine, and human prions in transgenic mice. J.Virol. 79 (2005) 5259-5271
27. Widenbrant M.I.O., Rajadas J., Sutardja C., and Fuller G.G. Lipid-induced β-amyloid peptide assemblage fragmentation. Biophys. J. 91 (2006) 4071-4080
28. Stahl N., Borchelt D.R., Hsiao K., and Prusiner S.B. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51 (1987) 229-240
29. Baron G.S., Wehrly K., Dorward D.W., Chesebro B., and Caughey B. Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(Sc)) into contiguous membrane. EMBO J. 21 (2002) 1031-1040
30. Lee K.S., and Caughey B. A simplified recipe for prions. Proc. Natl Acad. Sci. USA 104 (2007) 9551-9552
31. Tatzelt J., Zuo J., Voellmy R., Scott M., Hartl U., Prusiner S.B., and Welch W.J. Scrapie prions selectively modify the stress response in neuroblastoma cells. Proc. Natl Acad. Sci. USA 92 (1995) 2944-2948
32. Winklhofer K.F., Reintjes A., Hoener M.C., Voelmy R., and Tatzelt J. Geldanamycin restores a defective heat shock response in vivo. J. Biol. Chem. 276 (2001) 45160-45167
33. Jin T., Gu Y., Zanusso G., Sy M., Kumar A., Cohen M., et al. The chaperone protein BiP binds to a mutant prion protein and mediates its degradation by the proteasome. J. Biol. Chem. 275 (2000) 38699-38704
34. DebBurman S.K., Raymond G.J., Caughey B., and Lindquist S. Chaperone-supervised conversion of prion protein to its protease-resistant form. Proc. Natl Acad. Sci. USA 94 (1997) 13938-13943
35. Stockel J., and Hartl F.U. Chaperonin-mediated de novo generation of prion protein aggregates. J. Mol. Biol. 313 (2001) 861-872
36. Kenward N., Hope J., Landon M., and Mayer R.J. Expression of polyubiquitin and heat-shock protein 70 genes increases in the later stages of disease progression in scrapie-infected mouse brain. J. Neurochem. 62 (1994) 1870-1877
37. 2-microglobulin in astrocytes during scrapie. Microb. Pathog. 15 (1993) 1-6
38. Hetz C., Russelakis-Carneiro M., Walchli S., Carboni S., Vial-Knecht E., Maundrell K., et al. The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity. J. Neurosci. 25 (2005) 2793-2802
39. Sondheimer N., and Lindquist S. Rnq1: an epigenetic modifier of protein function in yeast. Mol. Cell 5 (2000) 163-172
40. Moriyama H., Edskes H.K., and Wickner R.B. [URE3] prion propagation in Saccharomyces cerevisiae: requirement for chaperone Hsp104 and curing by overexpressed chaperone Ydj1p. Mol. Cell. Biol. 20 (2000) 8916-8922
41. Inoue Y., Taguchi H., Kishimoto A., and Yoshida M. Hsp104 binds to yeast Sup35 prion fiber but needs other factor(s) to sever it. J. Biol. Chem. 279 (2004) 52319-52323
42. +] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104. J. Biol. Chem. 278 (2003) 49638-49643
43. Saborio G.P., Permanne B., and Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411 (2001) 810-813
44. Castilla J., Saa P., Hetz C., and Soto C. In vitro generation of infectious scrapie prions. Cell 121 (2005) 195-206
45. Silveira J.R., Raymond G.J., Hughson A., Race R.E., Sim V.L., Hayes S.F., and Caughey B. The most infectious prion protein particles. Nature 437 (2005) 257-261
46. Caughey B., and Lansbury P.T. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26 (2003) 267-298
47. Laksanalamai P., Maeder D.L., and Robb F.T. Regulation and mechanism of action of the small heat shock protein from the hyperthermophilic archaeon Pyrococcus furiosus. J. Bacteriol. 183 (2001) 5198-5202